Tumor-associated neutrophils expressing CCL2+ or CCL17+ promote BMP-2 and TGF-β2 secretion, thereby enhancing miR-301b-3p expression via paracrine signaling and activating the NF-κB signaling pathway. The gene discussed is CCL2; the disease is neoplasm.